article thumbnail

Hit-finding strategies for potent and specific molecules

Drug Discovery World

Synthetic, medicinal, and computational chemistry capabilities along with in house available diversity and focused libraries. Small molecule and biologics targeted screening for GPCRs, kinases, ion channels, interleukins, checkpoints, novel targets and a few case studies.

article thumbnail

AI in Drug Discovery - A Highly Opinionated Literature Review (Part III)

Practical Cheminformatics

Property Prediction Machine Learning Methods for Small Data Challenges in Molecular Science [link] Practical guidelines for the use of gradient boosting for molecular property prediction [link] Application of message passing neural networks for molecular property prediction [link] Molecular Similarity Molecular Similarity: Theory, Applications, and (..)

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Latest guide: Hit-finding strategies for potent and specific molecules

Drug Discovery World

Synthetic, medicinal, and computational chemistry capabilities along with in house available diversity and focused libraries. Small molecule and biologics targeted screening for GPCRs, kinases, ion channels, interleukins, checkpoints, novel targets and a few case studies.

article thumbnail

Sygnature Discovery and Daewoong Pharma announce research collaboration

Sygnature Discovery

Sygnature Discovery is pleased to have entered into a research collaboration agreement with the global healthcare group Daewoong Pharmaceutical to accelerate the discovery of a novel small molecule to target autoimmune disease.

article thumbnail

Optibrium acquires BioPharmics

Drug Discovery World

In their new roles, Ajay and Ann will continue the research and application of novel methods to extend the application of 3D modelling to traditional small molecules, as well as to beyond Rule-of-Five compounds that are becoming increasingly prevalent in drug discovery.

article thumbnail

Target-directed cancer: protein-ligand interactions  

Drug Target Review

The mission of the CCDD is to discover novel small-molecule therapeutics for the treatment of cancer and progress them to hypothesis testing phase 1 clinical trials. For example, in the screening stage of a project we are trying to find initial starting points for optimisation by our medicinal and computational chemistry colleagues.

article thumbnail

Accelerating Innovation, Deepening Integration | Viva Biotech Online Investor Day Review

The Pharma Data

As well as continuously upgrading and optimizing existing 9 major technology platforms, Viva has also invested heavily in the fields of Cryo-EM, Computational Chemistry/Biology, etc. Dr. Xueheng Cheng, CTO of Viva Biotech, introduced the ASMS technology platform.